HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on "Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness".
作者信息
Shin Gyeongseon, Kim Beom Kyung, Bae SeungJin, Lee Hankil, Ahn Sang Hoon
机构信息
College of Pharmacy, Ewha Womans University, Seoul, Korea.
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2025 Apr;31(2):e163-e165. doi: 10.3350/cmh.2024.1057. Epub 2024 Nov 29.
Abstract
摘要
相似文献
1
HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on "Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness".丙型肝炎病毒自我检测：弥合筛查差距并确保高危人群和普通人群的成本效益：致关于“按照世界卫生组织目标消除丙型肝炎的自我检测策略：疾病负担和成本效益分析”的社论的信函
Clin Mol Hepatol. 2025 Apr;31(2):e163-e165. doi: 10.3350/cmh.2024.1057. Epub 2024 Nov 29.
2
Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness.根据世界卫生组织目标消除丙型肝炎的自我检测策略：疾病负担与成本效益分析
Clin Mol Hepatol. 2025 Jan;31(1):166-178. doi: 10.3350/cmh.2024.0484. Epub 2024 Oct 4.
3
Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on "Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness".全民自我检测作为韩国消除丙型肝炎病毒的一种经济高效手段：关于《按照世界卫生组织目标消除丙型肝炎的自我检测策略：疾病负担与成本效益分析》的社论
Clin Mol Hepatol. 2025 Apr;31(2):596-598. doi: 10.3350/cmh.2024.0992. Epub 2024 Nov 11.
4
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care.产前保健中普遍进行丙型肝炎检测的短期效果和长期成本效益。
Obstet Gynecol. 2019 Feb;133(2):289-300. doi: 10.1097/AOG.0000000000003062.
5
Optimization of hepatitis C virus screening strategies by birth cohort in Italy.意大利基于出生队列对丙型肝炎病毒筛查策略的优化。
Liver Int. 2020 Jul;40(7):1545-1555. doi: 10.1111/liv.14408. Epub 2020 Apr 2.
6
Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation.中国消除慢性丙型肝炎的普遍筛查和治疗：经济评估。
Public Health. 2024 Mar;228:186-193. doi: 10.1016/j.puhe.2024.01.012. Epub 2024 Feb 21.
7
Hepatitis C Elimination in Moldova Is Feasible and Cost-Saving: A Modeling Study.摩尔多瓦消除丙型肝炎是可行且具有成本效益的：一项建模研究。
J Infect Dis. 2023 Sep 13;228(Suppl 3):S189-S197. doi: 10.1093/infdis/jiad138.
8
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.直接作用、泛基因型治疗方案时代丙型肝炎病毒感染普遍筛查的成本效益。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):930-939.e9. doi: 10.1016/j.cgh.2018.08.080. Epub 2018 Sep 8.
9
Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.消除作为重大公共卫生威胁的病毒性肝炎的全球进展：对世卫组织成员国2017年应对情况的分析
JHEP Rep. 2019 May 10;1(2):81-89. doi: 10.1016/j.jhepr.2019.04.002. eCollection 2019 Aug.
10
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.印度旁遮普邦基于医疗机构的丙型肝炎筛查和治疗的成本效果及预算影响分析。
BMJ Open. 2021 Feb 15;11(2):e042280. doi: 10.1136/bmjopen-2020-042280.
引用本文的文献
1
Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023.全球 170 多个国家 1967 年至 2023 年疫苗相关格林-巴利综合征负担。
Sci Rep. 2024 Oct 19;14(1):24561. doi: 10.1038/s41598-024-74729-2.
本文引用的文献
1
Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on "Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness".全民自我检测作为韩国消除丙型肝炎病毒的一种经济高效手段：关于《按照世界卫生组织目标消除丙型肝炎的自我检测策略：疾病负担与成本效益分析》的社论
Clin Mol Hepatol. 2025 Apr;31(2):596-598. doi: 10.3350/cmh.2024.0992. Epub 2024 Nov 11.
2
Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness.根据世界卫生组织目标消除丙型肝炎的自我检测策略：疾病负担与成本效益分析
Clin Mol Hepatol. 2025 Jan;31(1):166-178. doi: 10.3350/cmh.2024.0484. Epub 2024 Oct 4.
3
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study.韩国消除乙型和丙型肝炎病毒感染的核心指标：一项全国性研究。
Clin Mol Hepatol. 2023 Jul;29(3):779-793. doi: 10.3350/cmh.2023.0110. Epub 2023 May 15.
4
Cost-effectiveness of chronic hepatitis C screening and treatment.慢性丙型肝炎筛查与治疗的成本效益
Clin Mol Hepatol. 2022 Apr;28(2):164-173. doi: 10.3350/cmh.2021.0193. Epub 2021 Dec 27.
5
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.韩国基于社会视角的丙型肝炎病毒感染普遍筛查的成本效益研究。
Clin Mol Hepatol. 2022 Jan;28(1):91-104. doi: 10.3350/cmh.2021.0236. Epub 2021 Nov 5.
6
Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis.男男性行为者中丙型肝炎病毒感染的流行率和发病率：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):39-56. doi: 10.1016/S2468-1253(20)30303-4. Epub 2020 Nov 18.
Zotero 插件